Granulocyte-Macrophage Colony-Stimulating Factor Expressed by Recombinant Respiratory Syncytial Virus Attenuates Viral Replication and Increases the Level of Pulmonary Antigen-Presenting Cells

An obstacle to developing a vaccine against human respiratory syncytial virus (RSV) is that natural infection typically does not confer solid immunity to reinfection. To investigate methods to augment the immune response, recombinant RSV (rRSV) was constructed that expresses murine granulocyte-macro...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Virol
Principais autores:	Bukreyev, Alexander, Belyakov, Igor M., Berzofsky, Jay A., Murphy, Brian R., Collins, Peter L.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2001
Assuntos:	Vaccines and Antiviral Agents
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC116109/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11711604/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.75.24.12128-12140.2001
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!